Qiwei Jiang

2.6k total citations · 1 hit paper
61 papers, 1.9k citations indexed

About

Qiwei Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiwei Jiang has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Qiwei Jiang's work include Cancer-related molecular mechanisms research (9 papers), Cancer-related Molecular Pathways (6 papers) and Cancer Mechanisms and Therapy (6 papers). Qiwei Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Cancer-related Molecular Pathways (6 papers) and Cancer Mechanisms and Therapy (6 papers). Qiwei Jiang collaborates with scholars based in China, United States and Macao. Qiwei Jiang's co-authors include Zhi Shi, Jianping Guo, Meng-Ning Wei, Wenji Zhang, Jian-Ge Qiu, Xiao-Long Mei, Wu-Ming Qin, Zicheng Sun, Xueji Wu and Jia-Rong Huang and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Research.

In The Last Decade

Qiwei Jiang

60 papers receiving 1.9k citations

Hit Papers

High-fat diet promotes liver tumorigenesis via palmitoyla... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiwei Jiang China 27 1.1k 421 389 259 166 61 1.9k
Ansar Karimian Iran 23 1.5k 1.3× 466 1.1× 563 1.4× 166 0.6× 147 0.9× 38 2.4k
Rezvan Najafi Iran 27 1.3k 1.1× 540 1.3× 680 1.7× 222 0.9× 268 1.6× 122 2.7k
Nasser Samadi Iran 34 1.6k 1.5× 412 1.0× 502 1.3× 198 0.8× 195 1.2× 98 2.9k
Antonio Pezone Italy 15 1.2k 1.1× 280 0.7× 371 1.0× 208 0.8× 206 1.2× 30 2.3k
Rakesh Naidu Malaysia 27 1.2k 1.1× 484 1.1× 464 1.2× 168 0.6× 177 1.1× 91 2.4k
Penghong Song China 23 1.0k 0.9× 301 0.7× 229 0.6× 199 0.8× 112 0.7× 66 1.7k
Claudia Ceci Italy 15 1.2k 1.0× 444 1.1× 329 0.8× 134 0.5× 225 1.4× 23 2.1k
Yangzom D. Bhutia United States 29 1.6k 1.5× 536 1.3× 716 1.8× 199 0.8× 212 1.3× 60 2.8k
Cristina Sánchez‐de‐Diego Spain 14 842 0.8× 523 1.2× 379 1.0× 218 0.8× 132 0.8× 26 1.8k
Yong Xia China 27 903 0.8× 568 1.3× 232 0.6× 321 1.2× 286 1.7× 77 2.0k

Countries citing papers authored by Qiwei Jiang

Since Specialization
Citations

This map shows the geographic impact of Qiwei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiwei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiwei Jiang more than expected).

Fields of papers citing papers by Qiwei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiwei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiwei Jiang. The network helps show where Qiwei Jiang may publish in the future.

Co-authorship network of co-authors of Qiwei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiwei Jiang. A scholar is included among the top collaborators of Qiwei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiwei Jiang. Qiwei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Peipei, Qiwei Jiang, Xiaobo Wu, et al.. (2025). Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges. The Innovation. 6(8). 100918–100918.
2.
Zhang, Yi, Yaqing Su, Xueji Wu, et al.. (2025). High-protein diets alleviate tumour growth and drug resistance by promoting AKT aggregation and turnover. Gut. 74(10). 1711–1727. 1 indexed citations
3.
Jiang, Qiwei, Lang Bu, & Jianping Guo. (2025). Insights into palmitoylation-mediated regulation of inflammasomes. Trends in Immunology. 46(4). 266–269. 4 indexed citations
4.
Jiang, Qiwei, Yong Li, Songwang Cai, et al.. (2023). GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer. Acta Pharmaceutica Sinica B. 14(2). 698–711. 9 indexed citations
5.
Dai, Xiaoming, Cong Jiang, Qiwei Jiang, et al.. (2023). AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation. Nature Metabolism. 5(2). 265–276. 23 indexed citations
6.
Zhang, Xiaomei, Qiwei Jiang, Yaqing Su, et al.. (2023). AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy. British Journal of Cancer. 128(8). 1452–1465. 21 indexed citations
7.
Jiang, Qiwei, Xiaomei Zhang, Xiaoming Dai, et al.. (2022). S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions. Nature Communications. 13(1). 1548–1548. 43 indexed citations
8.
Xie, Wei, Qiwei Jiang, Xueji Wu, et al.. (2022). IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis. Cell Death and Differentiation. 29(8). 1528–1540. 24 indexed citations
9.
Zhang, Deyu, Jingyi Chen, Qiwei Jiang, et al.. (2022). Interaction between BEND5 and RBPJ suppresses breast cancer growth and metastasis via inhibiting Notch signaling. International Journal of Biological Sciences. 18(10). 4233–4244. 7 indexed citations
10.
Jiang, Qiwei, Nana Zheng, Lang Bu, et al.. (2021). SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Molecular Cancer. 20(1). 100–100. 57 indexed citations
11.
An, Xin, Xi Lin, Anli Yang, et al.. (2020). Cavin3 Suppresses Breast Cancer Metastasis via Inhibiting AKT Pathway. Frontiers in Pharmacology. 11. 1228–1228. 3 indexed citations
12.
Liu, Juan, Siyuan Zhao, Qiwei Jiang, et al.. (2020). Long noncoding RNA MYLK-AS1 promotes growth and invasion of hepatocellular carcinoma through the EGFR/HER2-ERK1/2 signaling pathway. International Journal of Biological Sciences. 16(11). 1989–2000. 14 indexed citations
13.
Xu, Lina, Na Zhao, Jinyan Chen, et al.. (2019). Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo. Frontiers in Oncology. 9. 2–2. 44 indexed citations
14.
Wang, Kun, Zihao Xing, Qiwei Jiang, et al.. (2019). Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance. Frontiers in Oncology. 9. 80–80. 28 indexed citations
15.
Chandler, Heather L., Tao Tan, Chunlin Yang, et al.. (2019). MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents. Communications Biology. 2(1). 71–71. 38 indexed citations
16.
Li, Pei, Zihao Xing, Jinming Di, et al.. (2018). Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma. Frontiers in Pharmacology. 9. 1041–1041. 21 indexed citations
17.
Li, Yong, Meng-Ning Wei, Yao Chen, et al.. (2016). Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer. Cancer Letters. 386. 100–109. 31 indexed citations
18.
Qiu, Jian-Ge, Yaojun Zhang, Jinming Zhao, et al.. (2015). Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget. 6(17). 15494–15509. 61 indexed citations
19.
Chen, Xiuxiu, Rongying Ou, Zhenzhen Zheng, et al.. (2015). Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752. Gynecologic Oncology. 140(3). 537–544. 60 indexed citations
20.
Hou, Zhenqing, Le Li, Peijuan Zhu, et al.. (2011). Preparation and in vitro evaluation of an ultrasound-triggered drug delivery system: 10-Hydroxycamptothecin loaded PLA microbubbles. Ultrasonics. 52(7). 836–841. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026